SCHEMBL29980324

SCHEMBL29980324

O=C(Cc1ccc(C(=O)Cc2cccc(F)c2)c(F)c1)c1cc(F)ccc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.49
HTT P42858 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
PIK3CA P42336 4/20 0.48
MAPT P10636 4/20 0.47
KDM4E B2RXH2 3/20 0.47
HSD17B10 Q99714 2/20 0.47
TP53 P04637 1/20 0.47
ALOX15 P16050 1/20 0.47
MAPK1 P28482 1/20 0.47
HIF1A Q16665 2/20 0.44
XBP1 P17861 1/20 0.44
NPC1 O15118 3/20 0.43
MEN1 O00255 2/20 0.43
HPGD P15428 2/20 0.43
TSHR P16473 2/20 0.43
KMT2A Q03164 2/20 0.43
RAB9A P51151 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAOB P27338 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL150248 0.92 HTT (0.50) LMNAHTTSMN1; SMN2PIK3CAMAPT
SCHEMBL29895835 0.92 HTT (0.50) LMNAHTTSMN1; SMN2PIK3CAMAPT
SCHEMBL29980557 0.86 LMNA (0.45) LMNAHTTSMN1; SMN2PIK3CAMAPT
SCHEMBL10561782 0.81 PIK3CA (0.68) LMNAHTTSMN1; SMN2PIK3CAMAPT
SCHEMBL11519 0.81 LMNA (0.55) LMNAHTTSMN1; SMN2PIK3CAMAPT
SCHEMBL11100 0.81 HPGD (0.47) LMNAHTTSMN1; SMN2PIK3CAMAPT
SCHEMBL30494456 0.81 HPGD (0.47) LMNAHTTSMN1; SMN2PIK3CAMAPT
SCHEMBL149865 0.80 HTT (0.61) LMNAHTTSMN1; SMN2PIK3CAMAPT
SCHEMBL10560970 0.80 LMNA (0.54) LMNAHTTSMN1; SMN2PIK3CAMAPT
SCHEMBL29980690 0.79 DGAT1 (0.49) LMNAHTTSMN1; SMN2PIK3CAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115141092-A Synthetic method of anti-lymphoma drug related compound 诚达药业股份有限公司 2022-10-04 CN claimed
CN-115141092-A Synthetic method of anti-lymphoma drug related compound 诚达药业股份有限公司 2022-10-04 CN disclosed